| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Email: |
eric_feng1954@126.com |
| Products Intro: |
Product Name:INAMRINONE LACTATE
CAS:75898-90-7
Purity:95% -98%HPLC Package:1GR;10GR;50GR;100GR;250GR;500GR;1KG;5KG;10KG;100KG
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Inamrinone lactate
CAS:75898-90-7
Package:50mg/RMB 13800;100mg/RMB 17500;25mg/RMB 10600
|
3-hydroxypropanoic acid manufacturers
- Inamrinone lactate
-
- $1980.00 / 50mg
-
2026-01-05
- CAS:75898-90-7
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 3-hydroxypropanoic acid Basic information |
| Product Name: | 3-hydroxypropanoic acid | | Synonyms: | (3,4'-Bipyridin)-6(1H)-one, 5-amino-, 3-hydroxypropanoate;3-Hydroxypropanoic acid compd. with 5-amino-(3,4'-bipyridin)-6(1H)-one;Amrinone lactate;Inamrinone lactate;Propanoic acid, 3-hydroxy-, compd. with 5-amino-(3,4'-bipyridin)-6(1H)-one;Unii-I229274Y5b;3-amino-5-pyridin-4-yl-1H-pyridin-2-one;DOSIONJFGDSKCQ-UHFFFAOYSA-N | | CAS: | 75898-90-7 | | MF: | C13H15N3O4 | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | 75898-90-7.mol |  |
| | 3-hydroxypropanoic acid Chemical Properties |
| | 3-hydroxypropanoic acid Usage And Synthesis |
| Uses | Amrinone lactate is a positive inotropic-vasodilator agent. Amrinone lactate is a selective phosphodiesterase III inhibitor that increases cyclic adenosine monophosphate by preventing its breakdown. Amrinone lactate is also an orally active, non-glycosidic and non-catecholamine cardiotonic agent[1][2][3]. | | Veterinary Drugs and Treatments | Inamrinone is considered a second line agent for the short-term
management
of CHF. It was originally called amrinone, but was
changed to inamrinone presumably to avoid confusion with
amiodarone. | | References | [1] A A Alousi, et al. The Beneficial Effect of Amrinone on Acute Drug-Induced Heart Failure in the Anaesthetised Dog. Cardiovasc Res. 1985 Aug;19(8):483-94. DOI:10.1093/cvr/19.8.483
[2] S Ichioka, et al. Clinical Use of Amrinone (A Selective Phosphodiesterase III Inhibitor) in Reconstructive Surgery. Plast Reconstr Surg. 2001 Dec;108(7):1931-7. DOI:10.1097/00006534-200112000-00013
[3] T H LeJemtel, et al. Amrinone: A New Non-Glycosidic, Non-Adrenergic Cardiotonic Agent Effective in the Treatment of Intractable Myocardial Failure in Man. Circulation. 1979 Jun;59(6):1098-104. DOI:10.1161/01.cir.59.6.1098
[4] M Hachisu, et al. [Effects of Amrinone, an Inhibitor of c-AMP-specific Phosphodiesterases, on Neointimal Hyperplasia After Balloon Injury in Rats]. Nihon Yakurigaku Zasshi. 1998 Oct;112(4):267-74. DOI:10.1254/fpj.112.267 |
| | 3-hydroxypropanoic acid Preparation Products And Raw materials |
|